Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
raffaella.buzzetti@uniroma1.it
Raffaella Buzzetti
Professore Ordinario
Struttura:
DIPARTIMENTO DI MEDICINA SPERIMENTALE
E-mail:
raffaella.buzzetti@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
IDegLira for the Real-World Treatment of Type 2 Diabetes in Italy: Protocol and Interim Results from the REX Observational Study
DIABETES THERAPY
2022
Role of continuous glucose monitoring in diabetic patients at high cardiovascular risk: an expert-based multidisciplinary Delphi consensus
CARDIOVASCULAR DIABETOLOGY
2022
Contribution of rare variants in monogenic diabetes-genes to early-onset type 2 diabetes
DIABETES & METABOLISM
2022
The sodium–glucose co-transporter-2 (SGLT2) inhibitors reduce platelet activation and thrombus formation by lowering NOX2-related oxidative stress: a pilot study
ANTIOXIDANTS
2022
Reduced early response to SARS-CoV2 vaccination in people with type 1 and type 2 diabetes, a six months follow-up study: The CoVaDiab study I
DIABETES/METABOLISM RESEARCH AND REVIEWS
2022
Immunoreactivities Against Different Tyrosine-Phosphatase 2 (IA-2)(256-760) Protein Domains Characterize Distinct Phenotypes in Subjects With LADA
FRONTIERS IN ENDOCRINOLOGY
2022
Adult-onset autoimmune diabetes
NATURE REVIEWS. DISEASE PRIMERS
2022
Comparative effectiveness and safety of glargine 300 U/mL versus degludec 100 U/mL in insulin-naïve patients with type 2 diabetes. A multicenter retrospective real-world study (RESTORE-2 NAIVE STUDY)
ACTA DIABETOLOGICA
2022
Comparative effectiveness of Glargine 300 U/mL vs. Degludec 100 U/mL in patients with type 2 diabetes switching from 1° generation basal insulins
NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
2022
Differential involvement of myelinated and unmyelinated nerve fibers in painful diabetic polyneuropathy
MUSCLE & NERVE
2021
Decrease of coronary heart disease risk with GLP1-receptor agonists or SGLT2 inhibitors therapy in patients with type 2 diabetes in primary cardiovascular prevention: A 24 months follow-up study
DIABETES RESEARCH AND CLINICAL PRACTICE
2021
Risk of cardiac autonomic neuropathy in latent autoimmune diabetes in adults is similar to type 1 diabetes and lower compared to type 2 diabetes: A cross-sectional study
DIABETIC MEDICINE
2021
Use of DPP4 inhibitors in Italy does not correlate with diabetes prevalence among COVID-19 deaths
DIABETES RESEARCH AND CLINICAL PRACTICE
2021
Similar glycaemic control and risk of hypoglycaemia with patient- versus physician-managed titration of insulin glargine 300 U/mL across subgroups of patients with T2DM: a post hoc analysis of ITAS
ACTA DIABETOLOGICA
2021
Differential involvement of myelinated and unmyelinated nerve fibers in painful diabetic polyneuropathy
MUSCLE & NERVE
2021
The complex combination of COVID-19 and diabetes: pleiotropic changes in glucose metabolism
ENDOCRINE
2021
Small nerve fiber damage and Langerhans cells in type 1 and type 2 diabetes and LADA measured by corneal confocal microscopy
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
2021
Effects of the COVID-19 lockdown on glycaemic control in subjects with type 2 diabetes: the glycalock study
DIABETES, OBESITY AND METABOLISM
2021
Digital intervention increases influenza vaccination rates for people with diabetes in a decentralized randomized trial
NPJ DIGITAL MEDICINE
2021
Short-term safety profile of Sars-Cov2 vaccination on glucose control. Continuous glucose monitoring data in people with autoimmune diabetes
DIABETES RESEARCH AND CLINICAL PRACTICE
2021
« prima
< precedente
1
2
3
4
5
6
7
8
seguente ›
ultima »
Progetti di Ricerca
Slowly progressive autoimmune diabetes: a clinical model for novel pathways of ß-cell protection
Nuovi marcatori di malattia vascolare nel diabete mellito: ruolo svolto da sclerostina, RUNX2 ed osteopontina nel meccanismo aterosclerotico.
Genetics and autoantibody heterogeneity of autoimmune diabetes: implications for precision medicine
Gruppi di ricerca - Responsabile
Intervento farmacologico inibente la differenziazione delle cellule mieloidi verso un fenotipo calcificante
Slowly progressive autoimmune diabetes: a clinical model for novel pathways of ß-cell protection
Molecular and pathophysiological heterogeneity of autoimmune diabetes: implications for precision medicine
Synergies anchoring to gravity (SynErg): a novel test to diagnose risk of falls in type 2 diabetes patients
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma